Trending Stocks Today | Galmed Pharmaceuticals Soars 416.53%
September 17th - US stocks trending in regular trading hours.Gainers: $Galmed Pharmaceuticals(GLMD.US)$ shoots up 416.53% to $19.99 with a turnover of $1.08 billion. $BurgerFi International(BFI.US)$
BioNTech Raised to Buy at Jefferies on New Cancer Drug
Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study
H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $45
H.C. Wainwright analyst Mitchell Kapoor maintains $Summit Therapeutics(SMMT.US)$ with a buy rating, and maintains the target price at $45.According to TipRanks data, the analyst has a success rate
A 160% surge in a week, one good medicine is enough to change fate! What is summit therapeutics (SMMT.US)?
In the US stock market last week, a stock called Summit Therapeutics (SMMT.US) rose unexpectedly, not only surging 160% itself, but also lifting biotechnology companies such as BioNTech and Instil Bio along with it.
Summit Therapeutics Reports High Response Rates From Ivonescimab Trials in Cancer Studies